NCT05336409
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05336409
Title A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies (ELiPSE-1)
Acronym ELiPSE-1
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Century Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Banner MD Anderson Cancer Center Gilbert Arizona 85234 United States Details
University of Southern California - Norris Comprehensive Cancer Center Los Angeles California 90033 United States Details
University of California San Diego, Moores Cancer Center San Diego California 92093 United States Details
Medstar Georgetown University Hospital Washington District of Columbia 20007 United States Details
University of Kentucky - Markey Cancer Center Lexington Kentucky 40536 United States Details
University of Maryland Medical Center Baltimore Maryland 21201 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
Corewell Health Grand Rapids Michigan 49503 United States Details
Levine Cancer Institute Charlotte North Carolina 28204 United States Details
University of Cincinnati Medical Center Cincinnati Ohio 45229 United States Details
Oncology Hematology Care, Inc-Kenwood Cincinnati Ohio 45236 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232 United States Details
UT Southwestern Dallas Texas 75390 United States Details
Houston Methodist Research Institute Houston Texas 77030 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
Swedish Cancer Institute Seattle Washington 98104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field